Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect.
To facilitate the repair of articular cartilage defects, autologous mesenchymal cells from bone marrow or periosteum were transplanted in a rabbit model. Two weeks after the transplantation of the mesenchymal cells, the whole area of the original defect was occupied by cartilage. From the deep area of the reparative cartilage, which contacted with host bone, chondrocytes became hypertrophic and the invasion of bone with vasculature started, until the replacement reached the natural junction of the host cartilage and the subchondral bone about 4 weeks after transplantation. Twelve weeks after the transplantation, the repair cartilage in the defect became a little thinner than the adjacent normal cartilage, which became a little thinner 24 weeks after the transplantation (the longest observation period in the study). Large, full-thickness defects of the weight-bearing region of the articular cartilage were repaired with hyaline-like cartilage after implantation of autologous mesenchymal cells. The repair process by mesenchymal cell transplantation was explained as follows: The donor transplanted cell differentiated into cartilage and the defects were completely filled with cartilage. Then, mesenchymal cells that entered the chondrogenic lineage rapidly progressed through this lineage to the hypertrophic state, which was then the target for erosion and vascular invasion. Although this vasculature and the newly formed bone were considered to be host-derived, there was no evidence to that effect. To prove this, suitable experimental marking of these donor cells is needed. In the case of chondrocyte transplantation, the repair cartilage maintained its thickness to the full depth of the original defect; the tissue derived from the implanted chondrocytes was not invaded by vessels or replaced by subchondral bone.
Wakitani
Shigeyuki
S
Department of Orthopaedic Surgery, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto 390-8621, Japan. wakitani@hsp.md.shinshu-u.ac.jp
Yamamoto
Tetsuya
T
D000818:Animals; D002357:Cartilage Diseases / Q000473:pathology* / Q000628:therapy*; D002358:Cartilage, Articular / Q000473:pathology* / Q000601:surgery*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D006801:Humans; D007719:Knee Joint / Q000473:pathology / Q000601:surgery; D008648:Mesoderm / Q000637:transplantation*; D020370:Osteoarthritis, Knee / Q000473:pathology / Q000628:therapy; D011817:Rabbits; D012038:Regeneration; D033581:Stem Cell Transplantation; D014945:Wound Healing